USA Financial Formulas’s Orthofix Medical OFIX Stock Holding History

USA Financial Formulas’s Portfolio OFIX Stock Details OFIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-1,627	Closed	-$96K	–	359
2018 Q2	$96K	Hold	1,627	–	–	0.02%	290
2018 Q1	$96K	Buy	+1,627	New	+$91.1K	0.02%	290
2016 Q3	–	Sell	-8,728	Closed	-$370K	–	284
2016 Q2	$370K	Buy	+8,728	New	+$379K	0.1%	163

Other funds holding OFIX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

SBH

Segall Bryant & Hamill Chicago, Illinois $8.43B AUM 52.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

USA Financial Formulas's OFIX Position: Q3 2018 in Review

USA Financial Formulas sold out of Orthofix Medical (OFIX) in Q3 2018, closing a stake of 1,627 shares — an estimated $96K sold.

USA Financial Formulas first reported a position in OFIX in Q2 2016 and held it in 3 quarters. The position peaked at $370K in Q2 2016. 162 funds tracked by Wall St. Rank hold OFIX as of Q3 2018.

USA Financial Formulas reported no remaining Orthofix Medical position as of Q3 2018 after selling out during the quarter.
USA Financial Formulas sold 1,627 Orthofix Medical shares in Q3 2018, an estimated $96K.
USA Financial Formulas first reported a position in Orthofix Medical in Q2 2016 and held it in 3 quarters.
USA Financial Formulas's Orthofix Medical position peaked at $370K in Q2 2016.
162 funds tracked by Wall St. Rank held Orthofix Medical as of Q3 2018.

Based on USA Financial Formulas's 13F filing for Q3 2018, filed 31 Oct 2018.